Reactogenicity, safety and immonogenicity of a recombinant bivaccine against smallpox and hepatitis B in limited clinical trials

This article has no abstract
Epistemonikos ID: 063d42aeb50f6181a202322b003e5389cc66fa5c
First added on: Feb 12, 2025